By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Suzuken Co., Ltd.

Suzuken Co., Ltd. (SZUKF)

OTC Market Data in USD, Fundamentals in JPY
$30.30
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$1.72B
Market Cap
9.89
P/E Ratio (TTM)
2.23%
Forward Dividend Yield
$30.30 - $30.30
52 Week Range

SZUKF Stock Price Chart

Explore Suzuken Co., Ltd. interactive price chart. Choose custom timeframes to analyze SZUKF price movements and trends.

SZUKF Company Profile

Discover essential business fundamentals and corporate details for Suzuken Co., Ltd. (SZUKF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Distribution

IPO Date

10 Sept 2013

Employees

13.09K

CEO

Shigeru Asano

Description

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.

SZUKF Financial Timeline

Browse a chronological timeline of Suzuken Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 11 May 2026

Upcoming earnings on 10 Feb 2026

Upcoming earnings on 12 Nov 2025

Revenue estimate is $638.14B.

Earnings released on 13 Aug 2025

EPS came in at $0.37 falling short of the estimated $0.45 by -18.97%, while revenue for the quarter reached $4.11B , missing expectations by -0.93%.

Earnings released on 13 May 2025

EPS came in at $0.36 surpassing the estimated $0.14 by +158.24%, while revenue for the quarter reached $3.86B , missing expectations by -1.28%.

Dividend declared on 13 May 2025

A dividend of $0.34 per share was announced, adjusted to $0.34.

Dividend declared on 13 May 2025

A dividend of $0.34 per share was announced, adjusted to $0.34. The dividend will be paid on 1 Dec 2025.

Earnings released on 12 Feb 2025

EPS came in at $0.87 surpassing the estimated $0.33 by +165.83%, while revenue for the quarter reached $4.08B , beating expectations by +1.38%.

Earnings released on 12 Nov 2024

EPS came in at $1.37 surpassing the estimated $1.15 by +19.13%, while revenue for the quarter reached $4.28B , beating expectations by +1.64%.

Earnings released on 9 Aug 2024

EPS came in at $0.40 surpassing the estimated $0.32 by +23.57%, while revenue for the quarter reached $3.62B , beating expectations by +0.89%.

Earnings released on 14 May 2024

EPS came in at $0.30 falling short of the estimated $0.55 by -45.80%, while revenue for the quarter reached $3.77B , missing expectations by -1.88%.

Dividend declared on 14 May 2024

A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 4 Jun 2025.

Dividend declared on 14 May 2024

A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 10 Dec 2024.

Earnings released on 9 Feb 2024

EPS came in at $0.85 surpassing the estimated $0.59 by +43.73%, while revenue for the quarter reached $4.43B , beating expectations by +1.79%.

Earnings released on 30 Sept 2023

EPS came in at $1.01 surpassing the estimated $0.54 by +87.38%, while revenue for the quarter reached $4.15B , beating expectations by +2.97%.

Earnings released on 30 Jun 2023

EPS came in at $0.28 , while revenue for the quarter reached $3.97B , beating expectations by +5.32%.

Earnings released on 27 Jun 2023

EPS came in at $0.20 , while revenue for the quarter reached $4.20B , beating expectations by +0.34%.

Dividend declared on 15 May 2023

A dividend of $0.26 per share was announced, adjusted to $0.26. The dividend was paid on 4 Jun 2024.

Dividend declared on 15 May 2023

A dividend of $0.27 per share was announced, adjusted to $0.27. The dividend was paid on 11 Dec 2023.

Earnings released on 10 Feb 2023

EPS came in at $85.55 , while revenue for the quarter reached $4.78B , beating expectations by +1.12%.

Earnings released on 11 Nov 2022

EPS came in at $92.87 , while revenue for the quarter reached $4.04B , beating expectations by +0.13%.

Earnings released on 10 Aug 2022

EPS came in at $30.49 , while revenue for the quarter reached $4.07B , beating expectations by +1.61%.

Earnings released on 11 May 2022

EPS came in at $13.17 , while revenue for the quarter reached $4.49B , beating expectations by +1.66%.

Dividend declared on 11 May 2022

A dividend of $0.27 per share was announced, adjusted to $0.27. The dividend was paid on 6 Jun 2023.

Dividend declared on 11 May 2022

A dividend of $0.25 per share was announced, adjusted to $0.25. The dividend was paid on 12 Dec 2022.

Earnings released on 9 Feb 2022

EPS came in at $46.24 , while revenue for the quarter reached $5.10B , missing expectations by -0.39%.

Earnings released on 11 Nov 2021

EPS came in at $109.13 , while revenue for the quarter reached $5.01B .

Earnings released on 6 Aug 2021

EPS came in at -$4.86 , while revenue for the quarter reached $4.85B .

Earnings released on 11 May 2021

EPS came in at $20.06 , while revenue for the quarter reached $4.72B .

Dividend declared on 11 May 2021

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 3 Jun 2022.

Dividend declared on 11 May 2021

A dividend of $0.32 per share was announced, adjusted to $0.32. The dividend was paid on 10 Dec 2021.

Earnings released on 3 Feb 2021

EPS came in at $19.37 , while revenue for the quarter reached $5.47B .

Earnings released on 5 Nov 2020

EPS came in at $66.78 , while revenue for the quarter reached $4.98B .

Dividend declared on 11 May 2020

A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 2 Jun 2021.

Dividend declared on 11 May 2020

A dividend of $0.34 per share was announced, adjusted to $0.34. The dividend was paid on 10 Dec 2020.

SZUKF Stock Performance

Access detailed SZUKF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run